1060 related articles for article (PubMed ID: 24292112)
1. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
3. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
[TBL] [Abstract][Full Text] [Related]
4. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
[TBL] [Abstract][Full Text] [Related]
5. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
Schwartz DA; White CM; Wise PE; Herline AJ
Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
7. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
8. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
9. Managing perianal Crohn's fistula in the anti-TNFα era.
Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
[TBL] [Abstract][Full Text] [Related]
10. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNFα Treatment Discontinuation.
Legué C; Brochard C; Bessi G; Wallenhorst T; Dewitte M; Siproudhis L; Bouguen G
Inflamm Bowel Dis; 2018 May; 24(6):1107-1113. PubMed ID: 29733370
[TBL] [Abstract][Full Text] [Related]
12. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
13. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
14. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Lahat A; Assulin Y; Beer-Gabel M; Chowers Y
J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167
[TBL] [Abstract][Full Text] [Related]
16. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
Papamichael K; Cheifetz AS
World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
[TBL] [Abstract][Full Text] [Related]
17. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
[TBL] [Abstract][Full Text] [Related]
18. Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE; Anderson FH; Bernstein CN; Chey WY; Feagan BG; Fedorak RN; Kamm MA; Korzenik JR; Lashner BA; Onken JE; Rachmilewitz D; Rutgeerts P; Wild G; Wolf DC; Marsters PA; Travers SB; Blank MA; van Deventer SJ
N Engl J Med; 2004 Feb; 350(9):876-85. PubMed ID: 14985485
[TBL] [Abstract][Full Text] [Related]
19. Review of local injection of anti-TNF for perianal fistulising Crohn's disease.
Adegbola SO; Sahnan K; Tozer PJ; Phillips RK; Faiz OD; Warusavitarne J; Hart A
Int J Colorectal Dis; 2017 Nov; 32(11):1539-1544. PubMed ID: 28900730
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
Echarri A; Castro J; Barreiro M; Carpio D; Pereira S; Lorenzo A
J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
